Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5T32GM008361
National Institutes of Health
Grant: U01 CA223976
National Cancer Institute
Grant: T32 CA229102
National Cancer Institute
Grant: CA013148
NCI NIH HHS
Grant: P30 CA013148
National Institutes of Health
Grant: 5T32CA229102-08
Surgical Oncology Research Training Program
National Institutes of Health
Grant: 5P30AR048311-08
Analytic and Preparative Cytometry Facility
National Institutes of Health
Grant: 5U01CA223976-05
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress
National Institutes of Health
Grant: 5T32GM008361-26
Medical Scientist Training Program
Fields of Study
Keywords
Sustainable Development Goals